The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
In Vivo Formation of 8-Epi-Prostaglandin F2αIs Increased in Hypercholesterolemia
Open accessAbstract
Abstract F 2-isoprostanes are bioactive prostaglandin (PG) -like compounds that are produced from arachidonic acid through a nonenzymatic process of lipid peroxidation catalyzed by oxygen free-radicals. 8-Epi-PGF 2α may amplify the platelet response to agonists, circulates in plasma, and is excreted in urine. We examined the hypothesis that the formation of 8-epi-PGF 2α is altered in patients with hypercholesterolemia and contributes to platelet activation in this setting. Urine samples were obtained from 40 hypercholesterolemic patients and 40 age- and sex-matched control subjects for measurement of immunoreactive 8-epi-PGF 2α. Urinary excretion of 11-dehydro-thromboxane (TX) B 2, a major metabolite of TXA 2, was measured as an in vivo index of platelet activation. Low-dose aspirin, indobufen, and vitamin E were used to investigate the mechanism of formation and effects of 8-epi-PGF 2α on platelet activation. Urinary 8-epi-PGF 2α was significantly (P=.0001) higher in hypercholesterolemic patients than in control subjects: 473±305 versus 205±95 pg/mg creatinine. Its rate of excretion was inversely related to the vitamin E content of LDL and showed a positive correlation with urinary 11-dehydro-TXB 2. Urinary 8-epi-PGF 2α was unchanged after 2-week dosing with aspirin and indobufen despite complete suppression of TX metabolite excretion. Vitamin E supplementation was associated with dose-dependent reductions in both urinary 8-epi-PGF 2α and 11-dehydro-TXB 2 by 34% to 36% and 47% to 58% at 100 and 600 mg daily, respectively. We conclude that the in vivo formation of the F 2-isoprostane 8-epi-PGF 2α is enhanced in the vast majority of patients with hypercholesterolemia. This provides an aspirin-insensitive mechanism possibly linking lipid peroxidation to amplification of platelet activation in the setting of hypercholesterolemia. Dose-dependent suppression of enhanced 8-epi-PGF 2α formation by vitamin E supplementation may contribute to the beneficial effects of antioxidant treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Stephens, N. G., Parsons, A., Brown, M. J., Schofield, P. M., Kelly, F., Cheeseman, K., & Mitchinson, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90866-1 · Cited by 2,148
Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T. M., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,899
Continuous Monitoring of in Vztro Oxidation of Human Low Density Lipoprotein
Esterbauer, H., Striegl, G., Puhl, H., & Rotheneder, M. (1989) · Free Radical Research Communications · doi:10.3109/10715768909073429 · Cited by 1,790
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
The oxidation hypothesis of atherosclerosis
Witztum, J. L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92346-9 · Cited by 1,389
Morrow, J. D., Frei, B., Longmire, A. W., Gaziano, J. M., Lynch, S. M., Shyr, Y., Strauss, W. E., Oates, J. A., & Roberts, L. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321804 · Cited by 1,339
Brown, B. G., Zhao, X. Q., Sacco, D. E., & Albers, J. J. (1993) · Circulation · doi:10.1161/01.cir.87.6.1781 · Cited by 821
Navab, M., Berliner, J. A., Watson, A. D., Hama, S. Y., Territo, M. C., Lusis, A. J., Shih, D. M., Van Lenten, B. J., Frank, J. S., Demer, L. L., et al. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.7.831 · Cited by 692
Modulation of Oxidant Stress In Vivo in Chronic Cigarette Smokers
Reilly, M., Delanty, N., Lawson, J. A., & FitzGerald, G. A. (1996) · Circulation · doi:10.1161/01.cir.94.1.19 · Cited by 612
Takahashi, K., Nammour, T. M., Fukunaga, M., Ebert, J., Morrow, J. D., Roberts, L. J., Hoover, R. L., & Badr, K. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115826 · Cited by 511
Dieber-Rotheneder, M., Puhl, H., Waeg, G., Striegl, G., & Esterbauer, H. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41962-5 · Cited by 467
Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.
FitzGerald, G. A., Pedersen, A. K., & Patrono, C. (1983) · Circulation · doi:10.1161/01.cir.67.6.1174 · Cited by 466
Self-citation[8] Single vertical spin density gradient ultracentrifugation
Chung, B. H., Segrest, J. P., Ray, M. J., Brunzell, J. D., Hokanson, J. E., Krauss, R. M., Beaudrie, K., & Cone, J. T. (1986) · Methods in Enzymology · doi:10.1016/0076-6879(86)28068-4 · Cited by 447
Reaven, P. D., Khouw, A., Beltz, W. F., Parthasarathy, S., & Witztum, J. L. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.4.590 · Cited by 405
Jha, P., Flather, M., Lonn, E., Farkouh, M., & Yusuf, S. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-11-199512010-00009 · Cited by 399
Plasma 8‐epi‐PGF2α levels are elevated in individuals with non‐insulin dependent diabetes mellitus
Gopaul, N. K., Änggård, E. E., Mallet, A. I., Betteridge, D. J., Wolff, S. P., & Nourooz-Zadeh, J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00649-t · Cited by 390
Princen, H. M., van Poppel, G., Vogelezang, C., Buytenhek, R., & Kok, F. J. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.5.554 · Cited by 349
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
Wang, Z., Ciabattoni, G., Créminon, C., Lawson, J., Fitzgerald, G. A., Patrono, C., & Maclouf, J. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12087-9 · Cited by 341
Self-citationα-Tocopherol Inhibits Aggregation of Human Platelets by a Protein Kinase C–Dependent Mechanism
Freedman, J. E., Farhat, J. H., Loscalzo, J., & Keaney, J. F. (1996) · Circulation · doi:10.1161/01.cir.94.10.2434 · Cited by 311
α-tocopherol consumption during low-density-lipoprotein oxidation
Jessup, W., Rankin, S. M., de Whalley, C. V., Hoult, J. R. S., Scott, J., & Leake, D. S. (1990) · Biochemical Journal · doi:10.1042/bj2650399 · Cited by 307
Jialal, I., & Grundy, S. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41515-9 · Cited by 295
Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein
Lynch, S., & Frei, B. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35737-0 · Cited by 285
Cylooxygenase-dependent Formation of the Isoprostane, 8-Epi Prostaglandin F2α
Pratico, D., Lawson, J. A., & FitzGerald, G. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9800 · Cited by 264
Lynch, S. M., Morrow, J. D., Roberts, L. J., & Frei, B. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117107 · Cited by 236
Estimated rate of thromboxane secretion into the circulation of normal humans.
Patrono, C., Ciabattoni, G., Pugliese, F., Pierucci, A., Blair, I. A., & FitzGerald, G. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112341 · Cited by 234
Self-citationSupplementation With Low Doses of Vitamin E Protects LDL From Lipid Peroxidation in Men and Women
Princen, H. M. G., van Duyvenvoorde, W., Buytenhek, R., van der Laarse, A., van Poppel, G., Leuven, J. A. G., & van Hinsbergh, V. W. M. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.3.325 · Cited by 222
Morrow, J. D., Minton, T. A., & Roberts, L. J. (1992) · Prostaglandins · doi:10.1016/0090-6980(92)90077-7 · Cited by 215
Praticò, D., Smyth, E. M., Violi, F., & FitzGerald, G. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14916 · Cited by 204
Generation of 8-Epiprostaglandin F by Human Monocytes
Praticó, D., & FitzGerald, G. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8919 · Cited by 187
Increased thromboxane biosynthesis in type IIa hypercholesterolemia.
Davì, G., Averna, M., Catalano, I., Barbagallo, C., Ganci, A., Notarbartolo, A., Ciabattoni, G., & Patrono, C. (1992) · Circulation · doi:10.1161/01.cir.85.5.1792 · Cited by 166
Self-citationAntioxidant Vitamins and Cardiovascular Disease
Buring, J. E., & Gaziano, J. M. (1997) · Preventive Nutrition · doi:10.1007/978-1-4757-6242-6_9 · Cited by 161
Awad, J. A., Morrow, J. D., Takahashi, K., & Roberts, L. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53593-6 · Cited by 158
Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients
Lavy, A., Brook, G. J., Dankner, G., Amotz, A. B., & Aviram, M. (1991) · Metabolism · doi:10.1016/0026-0495(91)90005-h · Cited by 156
Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine
Ciabattoni, G., Maclouf, J., Catella, F., FitzGerald, G. A., & Patrono, C. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90233-5 · Cited by 139
Self-citationLee, B. L., Chua, S.-C., Ong, H. Y., & Ong, C. N. (1992) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(92)80445-v · Cited by 126
Patrignani, P., Santini, G., Panara, M. R., Sciulli, M. G., Greco, A., Rotondo, M. T., di Giamberardino, M., Maclouf, J., Ciabattoni, G., & Patrono, C. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15535.x · Cited by 75
Self-citationYin, K., Halushka, P. V., Yan, Y. T., & Wong, P. Y. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22527-7 · Cited by 67
Zamburlini, A., Maiorino, M., Barbera, P., Roveri, A., & Ursini, F. (1995) · Analytical Biochemistry · doi:10.1006/abio.1995.9953 · Cited by 33
Cominacini, L., Pastorino, A. M., Garbin, U., Campagnola, M., de Santis, A., Davoli, A., Faccini, G., Bertozzo, L., Pasini, F., & Af, P. (1994) · PubMed · Cited by 27
Cited by
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
Self-citationVitamin E: function and metabolism
Brigelius‐Flohé, R., & Traber, M. G. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.10.1145 · Cited by 1,591
Vitamin E, antioxidant and nothing more
Traber, M. G., & Atkinson, J. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.024 · Cited by 1,478
Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
Tangvarasittichai, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.456 · Cited by 1,213
Metadata
- Authors
- Davi, G., Alessandrini, P., Mezzetti, A., Minotti, G., Bucciarelli, T., Costantini, F., Cipollone, F., Bon, G. B., Ciabattoni, G., & Patrono, C.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1997-11
- Volume
- 17
- Issue
- 11
- Pages
- 3230-3235
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2127743767
- Cited by
- 350
- References
- 44
- FWCI
- 14.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.